![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » Russia Approves Second COVID-19 Vaccine
Russia Approves Second COVID-19 Vaccine
October 14, 2020
Russia has approved a second COVID-19 vaccine, the EpiVacCorona vaccine developed at the Vector Institute in Siberia.
The approval was granted ahead of a planned 30,000-participant phase 3 trial.
In August, Russian approved Sputnik V, the world’s first COVID-19 vaccine, prompting international concern because it had not gone through a late-stage study. Sputnik V is currently undergoing phase 3 trials in Russia, Saudi Arabia, Belarus and the Philippines.
Upcoming Events
-
21Oct